• 应用研究 • Previous Articles     Next Articles

Clinical Analysis of Endovascular Treatment of TASC (Ⅱ) D-Type Femoral Artery Occlusion

lcunfa liu1, Xiujun ZHANG2   

  1. 1. Department of Vascular Surgery, Tianjin Hospital, Tianjin300211, China
    2.
  • Received:2013-09-25 Revised:2014-03-07 Published:2014-08-15 Online:2014-08-15
  • Contact: Xiujun ZHANG

Abstract: [Abstract] Objective   To investigate methods and results of endovascular treatment in TASC (Ⅱ) D-type femoral
artery occlusion.Methods   From January2012to May 2013, 26cases (26branches) of superficial femoral artery occlusion with endovascular treatment of TASC (Ⅱ) D-type superficial femoral artery occlusion were retrospectively reviewed. The effi?cacy was evaluated through ABI, CTA, DSA and symptoms improved.Results   26branches were treated with endovascular methods. Technical success rate was80.7% (21/26), including 13branche with stent implantation,6branches with Silver?hawk atherectomy and2branches with Viabahn stent implantation.All patients were followed up for a mean period of(10.3±1.2)months, primary patency rates at6months were69.2% in stent group,66.7% in Silverhawk atherectomy group and100% in Viabahn stent group.Conclusion   Endovascular treatment of TASC (Ⅱ) D-type femoral artery occlusion can lead to satisfactory short term patency rates, and Viabahn stent is the latest treatment.

Key words: femoral artery occlusion, stent, silverhawk atherectomy, viabahn stent